Today, joint pain is a fairly common problem for both the elderly and young people. The treatment of degenerative diseases of the joints and spine is a complex section in medicine for a number of reasons. One of them is the invariably progressive nature of the causes of this pathology.
A number of methods for treating OA with conservative therapy have been proposed includig chondroprotectors wich are now wide spread drugs, and have shown efficiency and high safety.
When a patient begins to feel severe pain in the joints, this indicates that some kind of deformation is occurring in them. According to the form of the change, the doctor can determine what the patient is sick with and what is the form of the disease. To prevent the complete “death” of cartilage, as well as to nourish its cells, experts suggest taking interesting drugs such as chondroprotectors.
Mucosat® is a Chondroitine sulphate intramuscular and intraarticular injection.
Mucosat® is an effective medicine to treat patients with degenerative diseases (Osteoarthritis) of limbs and spine joints.
With its’ chondroprotective, anti-inflammatory, analgesic effects Mucosat® can relieve joints pain, improve their mobility, and delay disease exacerbating.
Chondroitine sulphate is one of a pharmacological group called “Chondroprotectors”, it’s a natural glycosaminoglycan, consisting of repeating disaccharide units of glucuronic acid and N – acetyl – D – galactosamine, it plays an important role in biological processes. It is abundantly present in all connective tissues of mammals, especially in cartilage, skin, blood vessels, ligaments, tendons, axon terminals, and in the extracellular matrix.
The main indication of Mucosat® is for treatment of degenerative-dystrophic disease of the joints and spine:
For Osteoarthritis of the peripheral joints.
For intervertebral osteochondrosis and osteoarthrosis.
To accelerate the formation of bone marrow in fracture.
MUCOSAT® REDUCES INFLAMMATION AND JOINT PAIN
MUCOSAT® REDUCES STIFFNESS AND IMPROVES JOINT MOBILITY
MUCOSAT® PREVENTS CARTILAGE BREAKDOWN
MUCOSAT® NORMALIZES CARTILAGE TISSUE REPAIR PROCESSES
Taking Mucosat® allows to prolong the periods without pain in patients with degenerative diseases of joints and spine.
Mucosat® is administered in 2ml intramuscularly with interval of 1 day between injections (every other day)
Recommended course of Mucosat® treatment is from 10 to 20 injections, it is possible to repeat the course of treatment after 6 months.
Mucosat® combination of intraarticular and intramuscular routes of administration are possible.
3- 5 intraarticular injections of Mucosat® 200 mg are given with an interval of 3 days between each administration, followed by 16 intramuscular injections of 200 mg with an interval of 1 day between injections (every other day).